Robust Stable Cell Line Platform for Biologics Development Cell line development plays an essential role in drug development Consideration for cell line development, such as host cell line selection, vector engineering, clone selection and monoclonality Case study for different molecules Speaker: Hongxing Shi, Associate Director of Process Development, ProBio Date: Feb.28th, 2021 Time: 10:25-10:50AM UTC Watch now Speaker Profile. Hongxing Shi is in charge of the stable cell line development team, and has 13-year experience in cell line development and antibody expression. She led the platform establishment of stable cell line development in GenScript. She also has over 5-year experience in project management of biosimilar development Related Services ProCLD Cell Line Development Service ProBio ProCLD cell line development services will provide you the cell lines with accelerated timeline, high quality delivery and extensive understanding of drug development to help you get your own success. 14 weeks from gene synthesis to top clones. The yield titer can reach an average of 4.35g/L , up to 8.70g/L. ProBio has delivered 300+ cell line development projects and has got 9 IND approvals. « Previous Page ProBio Announces New Executive Appointments Next Page ProBio Accelerates Chimagen's Global Market Expansion, Paving the Way for Innovative Antibody Therapy » Contact us Phone: 1-877-436-7274 (Toll-Free); 1-732-885-9188 Fax: 1-732-210-0262
Latest WebinarsNavigating Biologics Challenges:Regulatory, Process Development, and Tech Transfer SolutionsPre-clinical DMPK Study and Generation of Toolbox to Facilitate PK/ADA AnalysisMultiple Solutions of Functional Leads Discovery and EngineeringAntibody Engineering and Developablity ServiceFind More Therapeutic Antibody Categories